Accuracy of Computational Pressure-fluid Dynamics Applied to Coronary Angiography to Derive Fractional Flow Reserve: FLASH FFR
Overview
Authors
Affiliations
Aims: Conventional fractional flow reserve (FFR) is measured invasively using a coronary guidewire equipped with a pressure sensor. A non-invasive derived FFR would eliminate risk of coronary injury, minimize technical limitations, and potentially increase adoption. We aimed to evaluate the diagnostic performance of a computational pressure-flow dynamics derived FFR (caFFR), applied to coronary angiography, compared to invasive FFR.
Methods And Results: The FLASH FFR study was a prospective, multicentre, single-arm study conducted at six centres in China. Eligible patients had native coronary artery target lesions with visually estimated diameter stenosis of 30-90% and diagnosis of stable or unstable angina pectoris. Using computational pressure-fluid dynamics, in conjunction with thrombolysis in myocardial infarction (TIMI) frame count, applied to coronary angiography, caFFR was measured online in real-time and compared blind to conventional invasive FFR by an independent core laboratory. The primary endpoint was the agreement between caFFR and FFR, with a pre-specified performance goal of 84%. Between June and December 2018, matched caFFR and FFR measurements were performed in 328 coronary arteries. Total operational time for caFFR was 4.54 ± 1.48 min. caFFR was highly correlated to FFR (R = 0.89, P = 0.76) with a mean bias of -0.002 ± 0.049 (95% limits of agreement -0.098 to 0.093). The diagnostic performance of caFFR vs. FFR was diagnostic accuracy 95.7%, sensitivity 90.4%, specificity 98.6%, positive predictive value 97.2%, negative predictive value 95.0%, and area under the receiver operating characteristic curve of 0.979.
Conclusions: Using wire-based FFR as the reference, caFFR has high accuracy, sensitivity, and specificity. caFFR could eliminate the need of a pressure wire, technical error and potentially increase adoption of physiological assessment of coronary artery stenosis severity.
Clinical Trial Registration: URL: http://www.chictr.org.cn Unique Identifier: ChiCTR1800019522.
Gurav A, Revaiah P, Tsai T, Miyashita K, Tobe A, Oshima A Front Cardiovasc Med. 2024; 11:1468888.
PMID: 39654943 PMC: 11625592. DOI: 10.3389/fcvm.2024.1468888.
Tanade C, Khan N, Rakestraw E, Ladd W, Draeger E, Randles A NPJ Digit Med. 2024; 7(1):236.
PMID: 39242829 PMC: 11379815. DOI: 10.1038/s41746-024-01216-3.
Xu T, Yu W, Ding D, Li C, Huang J, Kubo T J Soc Cardiovasc Angiogr Interv. 2024; 2(5):101043.
PMID: 39132390 PMC: 11308763. DOI: 10.1016/j.jscai.2023.101043.
Kim H, Noh S, Kim S, Chu H, Jung C, Kang S Sci Rep. 2024; 14(1):18630.
PMID: 39128936 PMC: 11317489. DOI: 10.1038/s41598-024-69153-5.
Li M, Peng X, Zheng N, Ai H, Zhao Y, Li H Rev Cardiovasc Med. 2024; 25(2):69.
PMID: 39077355 PMC: 11263136. DOI: 10.31083/j.rcm2502069.